Life-science briefing: Tuesday, March 11, 2008
TODAY’S HEADLINES:
Affinergy gets $3M in grants for biological “linkers” (release)
Specialty pharma EUSA raises $50M, spends $23M for public biotech Cytogen (release)
Calderome takes in $12M for cancer diagnostics (peHUB)
Pulse Health raises $2M for handheld free-radical device (release)
LifeMasters takes in $15M for wellness, disease-management programs (release)
Dubai Techno Park launched $300MVC fund for life sciences, other sectors (release)
Affinergy gets $3M in grants for biological “linkers” – Affinergy, a Duke University spinout in Research Triangle Park, N.C., received grants worth more… Continue Reading
Kyphon to buy St. Francis for $525M, boosting struggling venture firm USVP
Updated
St. Francis Medical Technologies, of Sunnyvale, a company that treats spinal injuries, will be acquired Kyphon of Sunnyvale, for as much as $725 million, the companies said.
This must be especially welcome for Silicon Valley venture firm US Venture Partners, a backer of St. Francis which has performed poorly lately (see data below). This deal comes just as St. Francis was about to go public; the offer was too good for St. Francis’ private investors to… Continue Reading